Processa Pharmaceuticals, Inc. (PCSA) Operating income 2016–2025
Processa Pharmaceuticals, Inc. (PCSA) annual operating income history from SEC filings — each fiscal year as reported.
-$14.0MFY2025 · since FY2016: -$1.9M → -$14.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.0M | -16.1% |
| FY2024 | -$12.1M | -5.2% |
| FY2023 | -$11.5M | +58.4% |
| FY2022 | -$27.5M | -126.9% |
| FY2021 | -$12.1M | +19.8% |
| FY2020 | -$15.1M | -284.6% |
| FY2019 | -$3.9M | +13.0% |
| FY2018 | -$4.5M | -151.0% |
| FY2017 | -$1.8M | +6.2% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice